[
    [
        {
            "time": "",
            "original_text": "【异动股】药明康德(02359-HK)涨3.52%",
            "features": {
                "keywords": [
                    "药明康德",
                    "异动股",
                    "涨幅"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】药明康德(02359-HK)涨3.52%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "药明康德(02359)子公司合全药业、药明生物(02269)与Tubulis达成战略合作，加速新一代抗体偶联药物临床研发",
            "features": {
                "keywords": [
                    "药明康德",
                    "战略合作",
                    "抗体偶联药物",
                    "临床研发"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "药明康德(02359)子公司合全药业、药明生物(02269)与Tubulis达成战略合作，加速新一代抗体偶联药物临床研发",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【国金晨讯】心动公司：如何从广告价值看TapTap未来空间？乳制品行业专题：估值处于低位，奶价周期或成竞争趋缓催化剂",
            "features": {
                "keywords": [
                    "心动公司",
                    "TapTap",
                    "乳制品行业",
                    "奶价周期",
                    "估值低位"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "互联网",
                    "消费品",
                    "乳制品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国金晨讯】心动公司：如何从广告价值看TapTap未来空间？乳制品行业专题：估值处于低位，奶价周期或成竞争趋缓催化剂",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]